Industry Research Reports
Home > Reports > Chemical & Material > Astragaloside IV- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Astragaloside IV- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Industry: Chemical & Material
Published Date: 2026-07-09
Pages: 127 Pages
Report ld: 6860177
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Astragaloside IV Market Size(US$)
CAGR 2026-2032
3.3%
Market Size,2032
USD 98
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 80.79 million
Market Forecast in 2032(Value)
US$ 98 million
CAGR
3.3%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Astragaloside IV was estimated to be worth US$ 78.46 million in 2025 and is projected to reach US$ 98 million, growing at a CAGR of 3.3% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Astragaloside IV cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Astragaloside IV extract from astragalus Root.
Plant extracts are substances or active substances with desired properties extracted from plant tissue and processed for a specific purpose. It is used in various fields, such as health foods, therapeutic drugs, cosmetics, processing aids, additives chemical substitutes. The market’s growth is driven by lifestyle changes, consumer awareness, increasing use of products based on natural ingredients, and biotechnology breakthroughs. Additionally, macroeconomic variables such as rising consumer disposable income, research and development, imports and exports, growth in the agriculture industry, population aging, and population growth have positively impacted the demand for plant extracts in recent years. It is also becoming increasingly popular in cosmetics, perfumes, pharmaceuticals, and dietary supplements. The plant extracts market was valued at USD 31.84 billion in 2022 and is expected to grow at a CAGR of 11.3% during the forecast period.
This report provides a comprehensive view of the global market for Astragaloside IV, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Astragaloside IV market size, estimations, and forecasts are presented in terms of sales volume (MT) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Astragaloside IV.
MARKET SEGMENTATION
By Company
- NandR Bio Industries
- Zenergy Korea Corporation
- Bio-norm
- Wuhan Vanz Pharm
- Shaanxi Pioneer Biotech
- Xi'an Lyphar Biotech
- Xian Pincredit Bio-Tech
- Shaanxi Fuheng (FH) Biotechnology
- Nanjing NutriHerb BioTech
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- 0.1
- 0.98
- Others
Segment by Application
- Food Industry
- Pharmaceuticals Industry
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Astragaloside IV manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Astragaloside IV sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Astragaloside IV sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Astragaloside IV Product Introduction
1.2 Global Astragaloside IV Market Size Forecast
1.2.1 Global Astragaloside IV Sales Value (2021–2032)
1.2.2 Global Astragaloside IV Sales Volume (2021–2032)
1.2.3 Global Astragaloside IV Sales Price (2021–2032)
1.3 Astragaloside IV Market Trends & Drivers
1.3.1 Astragaloside IV Industry Trends
1.3.2 Astragaloside IV Market Drivers & Opportunities
1.3.3 Astragaloside IV Market Challenges
1.3.4 Astragaloside IV Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Astragaloside IV Players Revenue Ranking (2025)
2.2 Global Astragaloside IV Revenue by Company (2021–2026)
2.3 Global Astragaloside IV Sales Volume Ranking of Players (2025)
2.4 Global Astragaloside IV Sales Volume by Company (2021–2026)
2.5 Global Astragaloside IV Average Price by Company (2021–2026)
2.6 Key Manufacturers Astragaloside IV Manufacturing Base and Headquarters
2.7 Key Manufacturers Astragaloside IV Product Offerings
2.8 Key Manufacturers Start of Mass Production of Astragaloside IV
2.9 Astragaloside IV Market Competitive Analysis
2.9.1 Astragaloside IV Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Astragaloside IV Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Astragaloside IV revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Astragaloside IV Market Classification
3.1 Introduction by Type
3.1.1 0.1
3.1.2 0.98
3.1.3 Others
3.1.4 Global Astragaloside IV Sales Value by Type
3.1.4.1 Global Astragaloside IV Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Astragaloside IV Sales Value, by Type (2021–2032)
3.1.4.3 Global Astragaloside IV Sales Value, by Type (%), 2021–2032
3.1.5 Global Astragaloside IV Sales Volume by Type
3.1.5.1 Global Astragaloside IV Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Astragaloside IV Sales Volume, by Type (2021–2032)
3.1.5.3 Global Astragaloside IV Sales Volume, by Type (%), 2021–2032
3.1.6 Global Astragaloside IV Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Food Industry
4.1.2 Pharmaceuticals Industry
4.1.3 Others
4.2 Global Astragaloside IV Sales Value by Application
4.2.1 Global Astragaloside IV Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Astragaloside IV Sales Value, by Application (2021–2032)
4.2.3 Global Astragaloside IV Sales Value, by Application (%), 2021–2032
4.3 Global Astragaloside IV Sales Volume by Application
4.3.1 Global Astragaloside IV Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Astragaloside IV Sales Volume, by Application (2021–2032)
4.3.3 Global Astragaloside IV Sales Volume, by Application (%), 2021–2032
4.4 Global Astragaloside IV Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Astragaloside IV Sales Value by Region
5.1.1 Global Astragaloside IV Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Astragaloside IV Sales Value by Region (2021–2026)
5.1.3 Global Astragaloside IV Sales Value by Region (2027–2032)
5.1.4 Global Astragaloside IV Sales Value by Region (%), 2021–2032
5.2 Global Astragaloside IV Sales Volume by Region
5.2.1 Global Astragaloside IV Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Astragaloside IV Sales Volume by Region (2021–2026)
5.2.3 Global Astragaloside IV Sales Volume by Region (2027–2032)
5.2.4 Global Astragaloside IV Sales Volume by Region (%), 2021–2032
5.3 Global Astragaloside IV Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Astragaloside IV Sales Value, 2021–2032
5.4.2 North America Astragaloside IV Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Astragaloside IV Sales Value, 2021–2032
5.5.2 Europe Astragaloside IV Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Astragaloside IV Sales Value, 2021–2032
5.6.2 Asia Pacific Astragaloside IV Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Astragaloside IV Sales Value, 2021–2032
5.7.2 South America Astragaloside IV Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Astragaloside IV Sales Value, 2021–2032
5.8.2 Middle East & Africa Astragaloside IV Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Astragaloside IV Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Astragaloside IV Sales Value and Sales Volume
6.2.1 Key Countries/Regions Astragaloside IV Sales Value, 2021–2032
6.2.2 Key Countries/Regions Astragaloside IV Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Astragaloside IV Sales Value, 2021–2032
6.3.2 United States Astragaloside IV Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Astragaloside IV Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Astragaloside IV Sales Value, 2021–2032
6.4.2 Europe Astragaloside IV Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Astragaloside IV Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Astragaloside IV Sales Value, 2021–2032
6.5.2 China Astragaloside IV Sales Value by Type (%), 2025 vs 2032
6.5.3 China Astragaloside IV Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Astragaloside IV Sales Value, 2021–2032
6.6.2 Japan Astragaloside IV Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Astragaloside IV Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Astragaloside IV Sales Value, 2021–2032
6.7.2 South Korea Astragaloside IV Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Astragaloside IV Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Astragaloside IV Sales Value, 2021–2032
6.8.2 Southeast Asia Astragaloside IV Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Astragaloside IV Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Astragaloside IV Sales Value, 2021–2032
6.9.2 India Astragaloside IV Sales Value by Type (%), 2025 vs 2032
6.9.3 India Astragaloside IV Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 NandR Bio Industries
7.1.1 NandR Bio Industries Company Information
7.1.2 NandR Bio Industries Introduction and Business Overview
7.1.3 NandR Bio Industries Astragaloside IV Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 NandR Bio Industries Astragaloside IV Product Offerings
7.1.5 NandR Bio Industries Recent Developments
7.2 Zenergy Korea Corporation
7.2.1 Zenergy Korea Corporation Company Information
7.2.2 Zenergy Korea Corporation Introduction and Business Overview
7.2.3 Zenergy Korea Corporation Astragaloside IV Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Zenergy Korea Corporation Astragaloside IV Product Offerings
7.2.5 Zenergy Korea Corporation Recent Developments
7.3 Bio-norm
7.3.1 Bio-norm Company Information
7.3.2 Bio-norm Introduction and Business Overview
7.3.3 Bio-norm Astragaloside IV Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Bio-norm Astragaloside IV Product Offerings
7.3.5 Bio-norm Recent Developments
7.4 Wuhan Vanz Pharm
7.4.1 Wuhan Vanz Pharm Company Information
7.4.2 Wuhan Vanz Pharm Introduction and Business Overview
7.4.3 Wuhan Vanz Pharm Astragaloside IV Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Wuhan Vanz Pharm Astragaloside IV Product Offerings
7.4.5 Wuhan Vanz Pharm Recent Developments
7.5 Shaanxi Pioneer Biotech
7.5.1 Shaanxi Pioneer Biotech Company Information
7.5.2 Shaanxi Pioneer Biotech Introduction and Business Overview
7.5.3 Shaanxi Pioneer Biotech Astragaloside IV Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Shaanxi Pioneer Biotech Astragaloside IV Product Offerings
7.5.5 Shaanxi Pioneer Biotech Recent Developments
7.6 Xi'an Lyphar Biotech
7.6.1 Xi'an Lyphar Biotech Company Information
7.6.2 Xi'an Lyphar Biotech Introduction and Business Overview
7.6.3 Xi'an Lyphar Biotech Astragaloside IV Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Xi'an Lyphar Biotech Astragaloside IV Product Offerings
7.6.5 Xi'an Lyphar Biotech Recent Developments
7.7 Xian Pincredit Bio-Tech
7.7.1 Xian Pincredit Bio-Tech Company Information
7.7.2 Xian Pincredit Bio-Tech Introduction and Business Overview
7.7.3 Xian Pincredit Bio-Tech Astragaloside IV Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Xian Pincredit Bio-Tech Astragaloside IV Product Offerings
7.7.5 Xian Pincredit Bio-Tech Recent Developments
7.8 Shaanxi Fuheng (FH) Biotechnology
7.8.1 Shaanxi Fuheng (FH) Biotechnology Company Information
7.8.2 Shaanxi Fuheng (FH) Biotechnology Introduction and Business Overview
7.8.3 Shaanxi Fuheng (FH) Biotechnology Astragaloside IV Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Shaanxi Fuheng (FH) Biotechnology Astragaloside IV Product Offerings
7.8.5 Shaanxi Fuheng (FH) Biotechnology Recent Developments
7.9 Nanjing NutriHerb BioTech
7.9.1 Nanjing NutriHerb BioTech Company Information
7.9.2 Nanjing NutriHerb BioTech Introduction and Business Overview
7.9.3 Nanjing NutriHerb BioTech Astragaloside IV Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Nanjing NutriHerb BioTech Astragaloside IV Product Offerings
7.9.5 Nanjing NutriHerb BioTech Recent Developments
8 Industry Chain Analysis
8.1 Astragaloside IV Industrial Chain
8.2 Astragaloside IV Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Astragaloside IV Sales Model
8.5.2 Sales Channels
8.5.3 Astragaloside IV Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Astragaloside IV Market Trends
Table 2. Astragaloside IV Market Drivers & Opportunities
Table 3. Astragaloside IV Market Challenges
Table 4. Astragaloside IV Market Restraints
Table 5. Global Astragaloside IV Revenue by Company (US$ Million), 2021–2026
Table 6. Global Astragaloside IV Revenue Market Share by Company (2021–2026)
Table 7. Global Astragaloside IV Sales Volume by Company (MT), 2021–2026
Table 8. Global Astragaloside IV Sales Volume Market Share by Company (2021–2026)
Table 9. Global Market Astragaloside IV Price by Company (USD/Kg), 2021–2026
Table 10. Key Manufacturers Astragaloside IV Manufacturing Base and Headquarters
Table 11. Key Manufacturers Astragaloside IV Product Type
Table 12. Key Manufacturers Start of Mass Production of Astragaloside IV
Table 13. Global Astragaloside IV Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Astragaloside IV revenue, 2025
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global Astragaloside IV Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global Astragaloside IV Sales Value by Type (US$ Million), 2021–2026
Table 18. Global Astragaloside IV Sales Value by Type (US$ Million), 2027–2032
Table 19. Global Astragaloside IV Sales Market Share in Value by Type (2021–2026)
Table 20. Global Astragaloside IV Sales Market Share in Value by Type (2027–2032)
Table 21. Global Astragaloside IV Sales Volume by Type: 2021 vs 2025 vs 2032 (MT)
Table 22. Global Astragaloside IV Sales Volume by Type (MT), 2021–2026
Table 23. Global Astragaloside IV Sales Volume by Type (MT), 2027–2032
Table 24. Global Astragaloside IV Sales Market Share in Volume by Type (2021–2026)
Table 25. Global Astragaloside IV Sales Market Share in Volume by Type (2027–2032)
Table 26. Global Astragaloside IV Price by Type (USD/Kg), 2021–2026
Table 27. Global Astragaloside IV Price by Type (USD/Kg), 2027–2032
Table 28. Global Astragaloside IV Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. Global Astragaloside IV Sales Value by Application (US$ Million), 2021–2026
Table 30. Global Astragaloside IV Sales Value by Application (US$ Million), 2027–2032
Table 31. Global Astragaloside IV Sales Market Share in Value by Application (2021–2026)
Table 32. Global Astragaloside IV Sales Market Share in Value by Application (2027–2032)
Table 33. Global Astragaloside IV Sales Volume by Application: 2021 vs 2025 vs 2032 (MT)
Table 34. Global Astragaloside IV Sales Volume by Application (MT), 2021–2026
Table 35. Global Astragaloside IV Sales Volume by Application (MT), 2027–2032
Table 36. Global Astragaloside IV Sales Market Share in Volume by Application (2021–2026)
Table 37. Global Astragaloside IV Sales Market Share in Volume by Application (2027–2032)
Table 38. Global Astragaloside IV Price by Application (USD/Kg), 2021–2026
Table 39. Global Astragaloside IV Price by Application (USD/Kg), 2027–2032
Table 40. Global Astragaloside IV Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 41. Global Astragaloside IV Sales Value by Region (US$ Million), 2021–2026
Table 42. Global Astragaloside IV Sales Value by Region (US$ Million), 2027–2032
Table 43. Global Astragaloside IV Sales Value by Region (%), 2021–2026
Table 44. Global Astragaloside IV Sales Value by Region (%), 2027–2032
Table 45. Global Astragaloside IV Sales Volume by Region (MT): 2021 vs 2025 vs 2032
Table 46. Global Astragaloside IV Sales Volume by Region (MT), 2021–2026
Table 47. Global Astragaloside IV Sales Volume by Region (MT), 2027–2032
Table 48. Global Astragaloside IV Sales Volume by Region (%), 2021–2026
Table 49. Global Astragaloside IV Sales Volume by Region (%), 2027–2032
Table 50. Global Astragaloside IV Average Price by Region (USD/Kg), 2021–2026
Table 51. Global Astragaloside IV Average Price by Region (USD/Kg), 2027–2032
Table 52. Key Countries/Regions Astragaloside IV Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 53. Key Countries/Regions Astragaloside IV Sales Value, (US$ Million), 2021–2026
Table 54. Key Countries/Regions Astragaloside IV Sales Value, (US$ Million), 2027–2032
Table 55. Key Countries/Regions Astragaloside IV Sales Volume, (MT), 2021–2026
Table 56. Key Countries/Regions Astragaloside IV Sales Volume, (MT), 2027–2032
Table 57. NandR Bio Industries Company Information
Table 58. NandR Bio Industries Introduction and Business Overview
Table 59. NandR Bio Industries Astragaloside IV Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021–2026)
Table 60. NandR Bio Industries Astragaloside IV Product Offerings
Table 61. NandR Bio Industries Recent Developments
Table 62. Zenergy Korea Corporation Company Information
Table 63. Zenergy Korea Corporation Introduction and Business Overview
Table 64. Zenergy Korea Corporation Astragaloside IV Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021–2026)
Table 65. Zenergy Korea Corporation Astragaloside IV Product Offerings
Table 66. Zenergy Korea Corporation Recent Developments
Table 67. Bio-norm Company Information
Table 68. Bio-norm Introduction and Business Overview
Table 69. Bio-norm Astragaloside IV Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021–2026)
Table 70. Bio-norm Astragaloside IV Product Offerings
Table 71. Bio-norm Recent Developments
Table 72. Wuhan Vanz Pharm Company Information
Table 73. Wuhan Vanz Pharm Introduction and Business Overview
Table 74. Wuhan Vanz Pharm Astragaloside IV Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021–2026)
Table 75. Wuhan Vanz Pharm Astragaloside IV Product Offerings
Table 76. Wuhan Vanz Pharm Recent Developments
Table 77. Shaanxi Pioneer Biotech Company Information
Table 78. Shaanxi Pioneer Biotech Introduction and Business Overview
Table 79. Shaanxi Pioneer Biotech Astragaloside IV Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021–2026)
Table 80. Shaanxi Pioneer Biotech Astragaloside IV Product Offerings
Table 81. Shaanxi Pioneer Biotech Recent Developments
Table 82. Xi'an Lyphar Biotech Company Information
Table 83. Xi'an Lyphar Biotech Introduction and Business Overview
Table 84. Xi'an Lyphar Biotech Astragaloside IV Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021–2026)
Table 85. Xi'an Lyphar Biotech Astragaloside IV Product Offerings
Table 86. Xi'an Lyphar Biotech Recent Developments
Table 87. Xian Pincredit Bio-Tech Company Information
Table 88. Xian Pincredit Bio-Tech Introduction and Business Overview
Table 89. Xian Pincredit Bio-Tech Astragaloside IV Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021–2026)
Table 90. Xian Pincredit Bio-Tech Astragaloside IV Product Offerings
Table 91. Xian Pincredit Bio-Tech Recent Developments
Table 92. Shaanxi Fuheng (FH) Biotechnology Company Information
Table 93. Shaanxi Fuheng (FH) Biotechnology Introduction and Business Overview
Table 94. Shaanxi Fuheng (FH) Biotechnology Astragaloside IV Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021–2026)
Table 95. Shaanxi Fuheng (FH) Biotechnology Astragaloside IV Product Offerings
Table 96. Shaanxi Fuheng (FH) Biotechnology Recent Developments
Table 97. Nanjing NutriHerb BioTech Company Information
Table 98. Nanjing NutriHerb BioTech Introduction and Business Overview
Table 99. Nanjing NutriHerb BioTech Astragaloside IV Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021–2026)
Table 100. Nanjing NutriHerb BioTech Astragaloside IV Product Offerings
Table 101. Nanjing NutriHerb BioTech Recent Developments
Table 102. Key Raw Materials Lists
Table 103. Key Suppliers of Raw Materials Lists
Table 104. Astragaloside IV Downstream Customers
Table 105. Astragaloside IV Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Astragaloside IV Product Picture
Figure 2. Global Astragaloside IV Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Astragaloside IV Sales Value (US$ Million), 2021–2032
Figure 4. Global Astragaloside IV Sales Volume (MT), 2021–2032
Figure 5. Global Astragaloside IV Sales Price (USD/Kg), 2021–2032
Figure 6. Astragaloside IV Report Years Considered
Figure 7. Global Astragaloside IV Players Revenue Ranking (US$ Million), 2025
Figure 8. Global Astragaloside IV Sales Volume Ranking of Players (MT), 2025
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Astragaloside IV Revenue in 2025
Figure 10. Astragaloside IV Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 11. 0.1 Picture
Figure 12. 0.98 Picture
Figure 13. Others Picture
Figure 14. Global Astragaloside IV Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Astragaloside IV Sales Value Market Share by Type, 2025 & 2032
Figure 16. Global Astragaloside IV Sales Volume by Type (MT), 2021 vs 2025 vs 2032
Figure 17. Global Astragaloside IV Sales Volume Market Share by Type, 2025 & 2032
Figure 18. Global Astragaloside IV Price by Type (USD/Kg), 2021–2032
Figure 19. Product Picture of Food Industry
Figure 20. Product Picture of Pharmaceuticals Industry
Figure 21. Product Picture of Others
Figure 22. Global Astragaloside IV Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global Astragaloside IV Sales Value Market Share by Application, 2025 & 2032
Figure 24. Global Astragaloside IV Sales Volume by Application (MT), 2021 vs 2025 vs 2032
Figure 25. Global Astragaloside IV Sales Volume Market Share by Application, 2025 & 2032
Figure 26. Global Astragaloside IV Price by Application (USD/Kg), 2021–2032
Figure 27. North America Astragaloside IV Sales Value (US$ Million), 2021–2032
Figure 28. North America Astragaloside IV Sales Value by Country (%), 2025 vs 2032
Figure 29. Europe Astragaloside IV Sales Value (US$ Million), 2021–2032
Figure 30. Europe Astragaloside IV Sales Value by Country (%), 2025 vs 2032
Figure 31. Asia Pacific Astragaloside IV Sales Value (US$ Million), 2021–2032
Figure 32. Asia Pacific Astragaloside IV Sales Value by Region (%), 2025 vs 2032
Figure 33. South America Astragaloside IV Sales Value (US$ Million), 2021–2032
Figure 34. South America Astragaloside IV Sales Value by Country (%), 2025 vs 2032
Figure 35. Middle East & Africa Astragaloside IV Sales Value (US$ Million), 2021–2032
Figure 36. Middle East & Africa Astragaloside IV Sales Value by Country (%), 2025 vs 2032
Figure 37. Key Countries/Regions Astragaloside IV Sales Value (%), 2021–2032
Figure 38. Key Countries/Regions Astragaloside IV Sales Volume (%), 2021–2032
Figure 39. United States Astragaloside IV Sales Value (US$ Million), 2021–2032
Figure 40. United States Astragaloside IV Sales Value by Type (%), 2025 vs 2032
Figure 41. United States Astragaloside IV Sales Value by Application (%), 2025 vs 2032
Figure 42. Europe Astragaloside IV Sales Value (US$ Million), 2021–2032
Figure 43. Europe Astragaloside IV Sales Value by Type (%), 2025 vs 2032
Figure 44. Europe Astragaloside IV Sales Value by Application (%), 2025 vs 2032
Figure 45. China Astragaloside IV Sales Value (US$ Million), 2021–2032
Figure 46. China Astragaloside IV Sales Value by Type (%), 2025 vs 2032
Figure 47. China Astragaloside IV Sales Value by Application (%), 2025 vs 2032
Figure 48. Japan Astragaloside IV Sales Value (US$ Million), 2021–2032
Figure 49. Japan Astragaloside IV Sales Value by Type (%), 2025 vs 2032
Figure 50. Japan Astragaloside IV Sales Value by Application (%), 2025 vs 2032
Figure 51. South Korea Astragaloside IV Sales Value (US$ Million), 2021–2032
Figure 52. South Korea Astragaloside IV Sales Value by Type (%), 2025 vs 2032
Figure 53. South Korea Astragaloside IV Sales Value by Application (%), 2025 vs 2032
Figure 54. Southeast Asia Astragaloside IV Sales Value (US$ Million), 2021–2032
Figure 55. Southeast Asia Astragaloside IV Sales Value by Type (%), 2025 vs 2032
Figure 56. Southeast Asia Astragaloside IV Sales Value by Application (%), 2025 vs 2032
Figure 57. India Astragaloside IV Sales Value (US$ Million), 2021–2032
Figure 58. India Astragaloside IV Sales Value by Type (%), 2025 vs 2032
Figure 59. India Astragaloside IV Sales Value by Application (%), 2025 vs 2032
Figure 60. Astragaloside IV Industrial Chain
Figure 61. Astragaloside IV Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Astragaloside IV market size from 2026 to 2032?
The annual compound growth rate of the global Astragaloside IV market is 3.3% 2026 to 2032.
What was the global market size of Astragaloside IV in 2032?
Which region is expected to have the highest market share?
What was the global market size of Astragaloside IV in 2026?
Which companies rank high in the global Astragaloside IV market?
Related Reports
Global Astragaloside IV Market Research Report 2026
The global Astragaloside IV market was valued at US$ 78.46 million in 2025 and is anticipated to reach US$ 98 million by 2032, at a CAGR of 3.3% from 2026 to 2032.
Published Date: 2026-04-25
Pages: 128
USD 2900.00
(Single User License)
Global Astragaloside IV Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Astragaloside IV market is projected to grow from US$ 76.2 million in 2024 to US$ 95.3 million by 2031, at a CAGR of 3.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-25
Pages: 131
USD 4900.00
(Single User License)
Global Astragaloside IV Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Astragaloside IV market size was US$ 76.2 million in 2024 and is forecast to a readjusted size of US$ 95.3 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 76
USD 4250.00
(Single User License)
Global Astragaloside IV Market Research Report 2025
The global market for Astragaloside IV was valued at US$ 76.2 million in the year 2024 and is projected to reach a revised size of US$ 95.3 million by 2031, growing at a CAGR of 3.3% during the forecast period.
Published Date: 2025-02-21
Pages: 89
USD 2900.00
(Single User License)
Astragaloside IV- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Astragaloside IV was estimated to be worth US$ 76.2 million in 2024 and is forecast to a readjusted size of US$ 95.3 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 94
USD 3950.00
(Single User License)
Global Astragaloside IV Market Insights, Forecast to 2030
Astragaloside IV extract from astragalus Root.
Published Date: 2024-04-07
Pages: 96
USD 4900.00
(Single User License)
Global Astragaloside IV Market Research Report 2024
Astragaloside IV extract from astragalus Root.
Published Date: 2024-01-10
Pages: 88
USD 2900.00
(Single User License)
Global Astragaloside IV Market Research Report 2026
The global Astragaloside IV market was valued at US$ 78.46 million in 2025 and is anticipated to reach US$ 98 million by 2032, at a CAGR of 3.3% from 2026 to 2032.
Published: 2026-04-25
Pages: 128
USD 2900.00 (Single User License)Global Astragaloside IV Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Astragaloside IV market is projected to grow from US$ 76.2 million in 2024 to US$ 95.3 million by 2031, at a CAGR of 3.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-25
Pages: 131
USD 4900.00 (Single User License)Global Astragaloside IV Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Astragaloside IV market size was US$ 76.2 million in 2024 and is forecast to a readjusted size of US$ 95.3 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 76
USD 4250.00 (Single User License)Global Astragaloside IV Market Research Report 2025
The global market for Astragaloside IV was valued at US$ 76.2 million in the year 2024 and is projected to reach a revised size of US$ 95.3 million by 2031, growing at a CAGR of 3.3% during the forecast period.
Published: 2025-02-21
Pages: 89
USD 2900.00 (Single User License)Astragaloside IV- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Astragaloside IV was estimated to be worth US$ 76.2 million in 2024 and is forecast to a readjusted size of US$ 95.3 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 94
USD 3950.00 (Single User License)Global Astragaloside IV Market Insights, Forecast to 2030
Astragaloside IV extract from astragalus Root.
Published: 2024-04-07
Pages: 96
USD 4900.00 (Single User License)Global Astragaloside IV Market Research Report 2024
Astragaloside IV extract from astragalus Root.
Published: 2024-01-10
Pages: 88
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now